Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $30.5 million.

  • CG Oncology's Total Current Liabilities rose 9531.67% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year increase of 9531.67%. This contributed to the annual value of $21.4 million for FY2024, which is 4990.88% up from last year.
  • As of Q3 2025, CG Oncology's Total Current Liabilities stood at $30.5 million, which was up 9531.67% from $30.4 million recorded in Q2 2025.
  • CG Oncology's 5-year Total Current Liabilities high stood at $30.5 million for Q3 2025, and its period low was $10.0 million during Q1 2024.
  • Moreover, its 3-year median value for Total Current Liabilities was $18.5 million (2024), whereas its average is $19.6 million.
  • As far as peak fluctuations go, CG Oncology's Total Current Liabilities surged by 4990.88% in 2024, and later surged by 15631.49% in 2025.
  • Over the past 3 years, CG Oncology's Total Current Liabilities (Quarter) stood at $14.3 million in 2023, then surged by 49.91% to $21.4 million in 2024, then soared by 42.87% to $30.5 million in 2025.
  • Its last three reported values are $30.5 million in Q3 2025, $30.4 million for Q2 2025, and $22.6 million during Q1 2025.